Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Outcomes of Allogeneic Transplantation for Adult T-Cell Leukemia/Lymphoma in Adolescents and Young Adult (AYA) and Young Patients

Hidehiro Itonaga, Takuya Fukushima, Koji Kato, Nobuaki Nakano, Takeharu Kato, Takashi Tanaka, Tetsuya Eto, Yasuo Mori, Toshiro Kawakita, Naoyuki Uchida, Yasushi Sawayama, Takahiro Fukuda, Yoshinobu Kanda, Yoshiko Atsuta, Makoto Yoshimitsu, Shigeo Fuji

Blood (2023) 142 (Supplement 1): 1707.

https://doi.org/10.1182/blood-2023-173590

Published: 2023

Journal Articles

Somatic Mutations and Loss of Heterozygosity of HLA Genes Are Frequently Occurred and Tightly Associated with Poor Prognosis in Adult T Cell Leukemia-Lymphoma

Keita Tamaki, MD, Satoko Morishima, MD PhD, Shingo Suzuki, PhD, Atsuko Shigenari, Ikumi Nomura, Yutaro Yokota, Kazuho Morichika, MD, Yukiko Nishi, MD PhD, Sawako Nakachi, MD PhD, Shiki Okamoto, PhD, Kennosuke Karube, MD PhD, Takuya Fukushima, MD PhD, Takashi Shiina, PhD, Hiroaki Masuzaki, MD PhD

Blood (2019) 134 (Supplement_1): 2785.

https://doi.org/10.1182/blood-2019-128070

Published: 2019

Journal Articles

Proteomic Profiling of HTLV-1 Carriers and ATL Patients Reveal TNFR2 As a Novel Diagnostic and Chemosensitivity Biomarker for ATL

Carmina Louise Hugo Guerrero, MS, Yoshiko Yamashita, PhD, Megumi Kuba-Miyara, PhD, Naoki Imaizumi, PhD, Shugo Sakihama, PhD, Masaki Hayashi, MD, Takashi Miyagi, MD PhD, Satoko Morishima, MD PhD, Kennosuke Karube, MD PhD, Yuetsu Tanaka, PhD, Hiroaki Masuzaki, MD PhD, Takuya Fukushima, MD PhD

Blood (2019) 134 (Supplement_1): 660.

https://doi.org/10.1182/blood-2019-129817

Published: 2019

Journal Articles

Possibility of a Risk-Adapted Treatment Strategy for Untreated Aggressive Adult T-Cell Leukemia-Lymphoma (ATL) Based on the ATL Prognostic Index: A Supplementary Analysis of the JCOG9801 Study

Kosuke Toyoda, MD, Kunihiro Tsukasaki, MD PhD, Ryunosuke Machida, Tomohiro Kadota, MD PhD, Takuya Fukushima, MD PhD, Kenji Ishitsuka, MD PhD, Dai Maruyama, MD PhD, Hirokazu Nagai, MD PhD

Blood (2018) 132 (Supplement 1): 1645.

https://doi.org/10.1182/blood-2018-99-112734

Published: 2018

Journal Articles

Treatment of relapsed adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation: the Nagasaki Transplant Group experience

Hidehiro Itonaga, Hideki Tsushima, Jun Taguchi, Takuya Fukushima, Hiroaki Taniguchi, Shinya Sato, Koji Ando, Yasushi Sawayama, Emi Matsuo, Reishi Yamasaki, Yasuyuki Onimaru, Daisuke Imanishi, Yoshitaka Imaizumi, Shinichiro Yoshida, Tomoko Hata, Yukiyoshi Moriuchi, Naokuni Uike, Yasushi Miyazaki

Blood (2013) 121 (1): 219–225.

https://doi.org/10.1182/blood-2012-07-444372

Published: 2013

Journal Articles

Prospective Nationwide Observational Study of Hepatitis B Virus (HBV) DNA Monitoring and Preemptive Antiviral Therapy for HBV Reactivation in Patients with B-Cell Non-Hodgkin Lymphoma Following Rituximab Containing Chemotherapy: Results of Interim Analysis.

Shigeru Kusumoto, MD, PhD, Yasuhito Tanaka, MD, PhD, Ritsuro Suzuki, M.D., Takashi Watanabe, MD, PhD, Masanobu Nakata, MD, Hirotaka Takasaki, MD, Noriyasu Fukushima, MD, PhD, Takuya Fukushima, MD, PhD, Yukiyoshi Moriuchi, MD, Kuniaki Itoh, MD, PhD, Kisato Nosaka, MD, PhD, Ilseung Choi, MD, Masashi Sawa, MD, PhD, Rumiko Okamoto, MD, Hideki Tsujimura, MD, PhD, Toshiki Uchida, MD, PhD, Sachiko Suzuki, MD, PhD, Masataka Okamoto, MD, PhD, Tsutomu Takahashi, MD, PhD, Isamu Sugiura, MD, PhD, Yasushi Onishi, MD, PhD, Mika Kohri, MD, PhD, Shinichiro Yoshida, MD, PhD, Rika Sakai, MD, Minoru Kojima, MD, PhD, Hiroyuki Takahashi, MD, PhD, Akihiro Tomita, MD, PhD, Dai Maruyama, MD, PhD, Yoshiko Atsuta, MD, PhD, Eiji Tanaka, MD, PhD, Takayo Suzuki, MD, PhD, Tomohiro Kinoshita, M.D., Ph.D., Michinori Ogura, MD, PhD, Masashi Mizokami, MD, PhD, Ryuzo Ueda, MD, PhD

Blood (2012) 120 (21): 2641.

https://doi.org/10.1182/blood.V120.21.2641.2641

Published: 2012

Journal Articles

Characterization of Long-Term Survivors and a Predictive Model for Aggressive Adult T-Cell Leukemia-Lymphoma (ATL): An Ancillary Study by the Japan Clinical Oncology Group, JCOG0902A

Blood (2011) 118 (21): 881.

https://doi.org/10.1182/blood.V118.21.881.881

Published: 2011

Journal Articles

A Prospective Feasibility Trial of Unrelated Bone Marrow Transplantation with Reduced Intensity Conditioning Regimen for Elderly Patients with Adult T-Cell Leukemia/Lymphoma (ATL),

Tetsuya Eto, MD, Ilseung Choi, MD, Ryuji Tanosaki, MD, Yoshifusa Takatsuka, MD, Atae Utsunomiya, MD, Shigeki Takemoto, MD, PhD, Jun Taguchi, MD, Takuya Fukushima, MD, Koji Kato, MD, PhD, Takanori Teshima, MD, PhD, Yoko Suehiro, MD, Takeharu Yamanaka, PhD, Jun Okamura, MD, Naokuni Uike, MD, PhD

Blood (2011) 118 (21): 4163.

https://doi.org/10.1182/blood.V118.21.4163.4163

Published: 2011

Journal Articles

Relationship between monoclonal gammopathy of undetermined significance and radiation exposure in Nagasaki atomic bomb survivors

Masako Iwanaga, Masuko Tagawa, Kunihiro Tsukasaki, Tatsuki Matsuo, Ken-ichi Yokota, Yasushi Miyazaki, Takuya Fukushima, Tomoko Hata, Yoshitaka Imaizumi, Daisuke Imanishi, Jun Taguchi, Sabro Momita, Shimeru Kamihira, Masao Tomonaga

Blood (2009) 113 (8): 1639–1650.

https://doi.org/10.1182/blood-2008-05-159665

Published: 2009

Includes: Supplemental data

Journal Articles

Expression of 67-Kda Laminin Receptor (67LR) Relates to the Aggressiveness and Poor Prognosis of AML: Modulation of the Expression of GM-CSF Receptor by 67LR.

Koji Ando, MD, Yasushi Miyazaki, Daisuke Imanishi, Masako Iwanaga, Hideki Tsushima, Jun Taguchi, Takuya Fukushima, Shinichiro Yoshida, Tomoko Hata, Masao Tomonaga, MD, PhD

Blood (2008) 112 (11): 926.

https://doi.org/10.1182/blood.V112.11.926.926

Published: 2008

Journal Articles

Donor-derived DNA in fingernails among recipients of allogeneic hematopoietic stem-cell transplants

Daisuke Imanishi, Yasushi Miyazaki, Reishi Yamasaki, Yasushi Sawayama, Jun Taguchi, Hideki Tsushima, Takuya Fukushima, Shinichiro Yoshida, Hiroshi Sasaki, Tomoko Hata, Masao Tomonaga

Blood (2007) 110 (7): 2231–2234.

https://doi.org/10.1182/blood-2007-02-071423

Published: 2007

Includes: Supplemental data

Journal Articles

Phase III Study of VCAP-AMP-VECP vs. Biweekly CHOP in Aggressive Adult T-Cell Leukemia-Lymphoma (ATLL): Japan Clinical Oncology Group Study, JCOG9801.

Kunihiro Tsukasaki, MD, PhD, Takuya Fukushima, Atae Utsunomiya, Syuichi Ikeda, Masato Masuda, Kensei Tobinai, Haruhiko Fukuda, Masanori Shimoyama, Masao Tomonaga, Tomomitu Hotta, Members of the Lymphoma Study Group of JCOG

Blood (2005) 106 (11): 812.

https://doi.org/10.1182/blood.V106.11.812.812

Published: 2005

NARROW

Outcomes of Allogeneic Transplantation for Adult T-Cell Leukemia/Lymphoma in Adolescents and Young Adult (AYA) and Young Patients

Somatic Mutations and Loss of Heterozygosity of HLA Genes Are Frequently Occurred and Tightly Associated with Poor Prognosis in Adult T Cell Leukemia-Lymphoma

Proteomic Profiling of HTLV-1 Carriers and ATL Patients Reveal TNFR2 As a Novel Diagnostic and Chemosensitivity Biomarker for ATL

Possibility of a Risk-Adapted Treatment Strategy for Untreated Aggressive Adult T-Cell Leukemia-Lymphoma (ATL) Based on the ATL Prognostic Index: A Supplementary Analysis of the JCOG9801 Study

Treatment of relapsed adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation: the Nagasaki Transplant Group experience

Prospective Nationwide Observational Study of Hepatitis B Virus (HBV) DNA Monitoring and Preemptive Antiviral Therapy for HBV Reactivation in Patients with B-Cell Non-Hodgkin Lymphoma Following Rituximab Containing Chemotherapy: Results of Interim Analysis.

Characterization of Long-Term Survivors and a Predictive Model for Aggressive Adult T-Cell Leukemia-Lymphoma (ATL): An Ancillary Study by the Japan Clinical Oncology Group, JCOG0902A

A Prospective Feasibility Trial of Unrelated Bone Marrow Transplantation with Reduced Intensity Conditioning Regimen for Elderly Patients with Adult T-Cell Leukemia/Lymphoma (ATL),

Relationship between monoclonal gammopathy of undetermined significance and radiation exposure in Nagasaki atomic bomb survivors

Expression of 67-Kda Laminin Receptor (67LR) Relates to the Aggressiveness and Poor Prognosis of AML: Modulation of the Expression of GM-CSF Receptor by 67LR.

Donor-derived DNA in fingernails among recipients of allogeneic hematopoietic stem-cell transplants

Phase III Study of VCAP-AMP-VECP vs. Biweekly CHOP in Aggressive Adult T-Cell Leukemia-Lymphoma (ATLL): Japan Clinical Oncology Group Study, JCOG9801.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only